4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-22-000012
Chief Financial Officer sold 5,000 shares at $14.64 ($73,200)
From the SEC's structured data for this filing
Trades in this filing
Greenstein Leonard M. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-15 | Sale : show line 1 in the form | −5,000 | $14.64 | $73,200 | 44,289 | D |
| Open-market sales · 5,000 sh · avg $14.64 · $73,200 | ||||||
Loading xslF345X03/wf-form4_167122772509088.xml…